Advertisement

Кодтерпин

Основна информация

  • Търговско наименование:
  • Кодтерпин (Codterpin)
  • Предлага се от:
  • Софарма АД
  • дозиране:
  • 10; x 400
  • Лекарствена форма:
  • таблетки
  • Композиция:
  • таблетки x 10; x 400
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици
Advertisement

Документи

Локализация

  • Предлага се в:
  • Кодтерпин (Codterpin)
    България
  • Език:
  • български

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Последна актуализация:
  • 09-08-2016

Листовка за пациента


20-9-2017

Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Health care professionals should develop a treatment plan when buprenorphine or methadone is used in combination with benzodiazepines or other CNS depressants.

FDA - U.S. Food and Drug Administration

31-8-2017

Keytruda (pembrolizumab) in Patients with Multiple Myeloma: FDA Statement - Two Clinical Trials on Hold

Keytruda (pembrolizumab) in Patients with Multiple Myeloma: FDA Statement - Two Clinical Trials on Hold

Risks associated with the use of Keytruda in combination with dexamethasone and an immunomodulatory agent (lenalidomide or pomalidomide) for the treatment of patients with multiple myeloma.

FDA - U.S. Food and Drug Administration

3-8-2017

FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.

FDA - U.S. Food and Drug Administration

28-4-2017

FDA approves new combination treatment for acute myeloid leukemia

FDA approves new combination treatment for acute myeloid leukemia

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML.

FDA - U.S. Food and Drug Administration

28-2-2017

FDA approves Xermelo for carcinoid syndrome diarrhea

FDA approves Xermelo for carcinoid syndrome diarrhea

The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.

FDA - U.S. Food and Drug Administration

2-2-2009

Consultation responses on the future reimbursement status of 5 combination products in ATC groups C07, C08 and C09

Consultation responses on the future reimbursement status of 5 combination products in ATC groups C07, C08 and C09

The Danish Medicines Agency's assessment of the future reimbursement status of 5 combination products in ATC groups C07, C08 and C09 for the treatment of cardiovascular diseases has been submitted for consultation with 11 December 2008 as the consultation deadline.

Danish Medicines Agency

20-11-2017

Bontril vs. Adipex

Bontril vs. Adipex

Bontril (phendimetrazine tartrate) and Adipex (phentermine) are appetite suppressants, used in combination with diet and exercise for the treatment of obesity.

US - RxList

10-11-2017

Neurontin vs. Zarontin

Neurontin vs. Zarontin

Zarontin (ethosuximide) and Neurontin (gabapentin) are anti-epileptic medications, also anticonvulsants, used alone or in combination with other medications to treat absence seizures (also called "petit mal" seizures) in adults and children. A difference is Neurontin is also used to treat nerve pain caused by shingles (herpes zoster).

US - RxList

8-11-2017

Enalapri

Enalapri

Enalapril is indicated for the treatment of hypertension, and for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis.

US - RxList

7-11-2017

Carbidopa/Levodopa

Carbidopa/Levodopa

Carbidopa/levodopa is a combination of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control.

US - RxList

31-10-2017

Ultracet vs. Lortab

Ultracet vs. Lortab

Ultracet (tramadol and acetaminophen) and Lortab 5/500 (hydrocodone bitartrate and acetaminophen) are combination medications prescribed for the short-term relief of moderate to severe pain.

US - RxList

20-10-2017

Bactrim vs. Cipro

Bactrim vs. Cipro

Bactrim (sulfamethoxazole and trimethoprim) is a combination of two antibiotics (a sulfa drug and a folic acid inhibitor) and Cipro (ciprofloxacin) is a quinolone antibiotic. Both drug are used to treat bacterial infections such as urinary tract infections, bronchitis and other lung infections. Bactrim is also used to treat ear infections (acute otitis media), Shigellosis, Pneumocystis pneumonia, traveler's diarrhea, and methicillin-resistant Staphylococcus aureus (MRSA). Cipro is also prescribed to trea...

US - RxList

20-10-2017

Dulera vs. Symbicort

Dulera vs. Symbicort

Dulera is a combination of a corticosteroid and a long-acting beta agonist, while Symbicort is a combination of a steroid and a long-acting bronchodilator.

US - RxList

21-8-2017

FDA Clears First Fixed-Dose Combination Treatment for Gout

FDA Clears First Fixed-Dose Combination Treatment for Gout

The US Food and Drug Administration (FDA) has approved Duzallo (Ironwood Pharmaceuticals), a fixed-dose oral combination of lesinurad (Zurampic, AstraZeneca) and allopurinol (multiple brands), for the treatment of hyperuricemia associated with gout in patients for whom target serum uric acid (sUA) levels have not been acheived with allopurinol alone.

US - RxList

16-8-2017

Immunotherapy in Cancer: Hits and Misses, but Charging Ahead

Immunotherapy in Cancer: Hits and Misses, but Charging Ahead

After the many success of immunotherapy in various cancer types over the last few years, recent news of failures has come as a bit of a shock. It was a bad day for AstraZeneca in July when stock shares plummeted by more than 16% —the highly anticipated results of the phase 3 MYSTIC trial in lung cancer failed to show that combination immunotherapy was more effective than standard chemotherapy.

US - RxList

14-8-2017

Carboplatin

Carboplatin

Carboplatin is an anti-cancer medication indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of carboplatin injection and cyclophosphamide. Carboplatin injection is also indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.

US - RxList

16-5-2017

Direct Comparison Favors Electrolyte Bowel Prep

Direct Comparison Favors Electrolyte Bowel Prep

For bowel cleanliness and readiness, polyethylene glycol is better than a combination of sodium picosulfate plus magnesium citrate, and split dosing over 2 days is more effective than split dosing over 1 day, according to a new study.

US - RxList

15-5-2017

Trimodal Therapy Best for Operable Anaplastic Thyroid Cancer

Trimodal Therapy Best for Operable Anaplastic Thyroid Cancer

Patients with operable anaplastic thyroid cancer have improved overall survival when treated with an aggressive trimodal approach using a combination of surgery followed by radiation and radio-sensitizing chemotherapy, according to a new study published in the May issue of Thyroid.

US - RxList

20-4-2017

Butalbital

Butalbital

Butalbital is discontinued. It was used in combination with acetaminophen or acetylsalicylic acid (aspirin) to treat pain and vascular headaches. Learn about side effects, drug interactions, dosages, warnings, and more.

US - RxList

5-4-2017

FDA Panel Wary of Analgesic-Antacid Combination Products

FDA Panel Wary of Analgesic-Antacid Combination Products

A US Food and Drug Administration (FDA) advisory panel voted 15 to 5 Tuesday, recommending that the combination of an analgesic with antacids is not "a rational combination for over-the-counter (OTC) use for the relief of minor aches and pains associated with heartburn, sour stomach, acid indigestion, fullness, belching, gas, or nausea."

US - RxList

5-4-2017

Analgesic-Antacid Combination Product Safety

Analgesic-Antacid Combination Product Safety

FDA Panel Wary of Analgesic-Antacid Combination Products

US - eMedicineHealth

14-3-2017

FDA Approves Kisqali for Advanced HR+ Breast Cancer

FDA Approves Kisqali for Advanced HR+ Breast Cancer

The US Food and Drug Administration (FDA) today approved ribociclib (Kisqali, Novartis) in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.

US - RxList

7-3-2017

New Biologic is Potential Blockbuster for Eczema Treatment

New Biologic is Potential Blockbuster for Eczema Treatment

Dupilumab, a new biologic generating excitement in dermatology, can be used in combination with topical corticosteroids to safely control the symptoms of moderate to severe eczema over the long term, including itch, according to new research.

US - RxList

27-2-2017

First Look at Combo With Immunotherapy in Untreated mRCC

First Look at Combo With Immunotherapy in Untreated mRCC

Use of the immunotherapy atezolizumab (Tecentriq, Roche) in combination with bevacizumab (Avastin, Roche) nearly doubled progression-free survival (PFS) compared with sunitinib (Sutent, Pfizer) as a first-line treatment in patients with locally advanced or metastatic renal cell carcinoma (mRCC).

US - RxList

14-2-2017

SUPER AQUA MAX COMBINATION WATERY (Dimethicone) Cream [NATURE REPUBLIC CO., LTD.]

SUPER AQUA MAX COMBINATION WATERY (Dimethicone) Cream [NATURE REPUBLIC CO., LTD.]

Updated Date: Feb 14, 2017 EST

US - DailyMed

17-1-2017

Exenatide-Pioglitazone Combo Tops Insulin in Type 2 Diabetes

Exenatide-Pioglitazone Combo Tops Insulin in Type 2 Diabetes

A combination of pioglitazone and the glucagonlike peptide 1 (GLP-1) agonist exenatide (Bydureon, AstraZeneca) may represent an effective and safe alternative to insulin for the treatment of type 2 diabetes in patients who are poorly controlled despite use of both metformin and a sulfonylurea.

US - RxList

12-1-2017

Chlorhexidine Effective Against Candida auris Biofilms

Chlorhexidine Effective Against Candida auris Biofilms

A combination of standard infection prevention measures and the use of disinfectant chlorhexidine should be used to combat the potential spread of Candida auris in hospital environments, according to a study published online January 11 in Emerging Infectious Diseases.

US - RxList

21-12-2016

EU/3/11/942 (Jazz Pharmaceuticals Ireland Ltd)

EU/3/11/942 (Jazz Pharmaceuticals Ireland Ltd)

EU/3/11/942 (Active substance: Liposomal combination of cytarabine and daunorubicin) - Transfer of orphan designation - Commission Decision (2016)8908 of Wed, 21 Dec 2016 European Medicines Agency (EMA) procedure number: EMA/OD/070/11/T/01

Europe -DG Health and Food Safety

Advertisement